fragile-x
Systematic review of pharmacological treatments in fragile X syndrome
11
EXPLAIN Fragile X: an explorative, longitudinal study on the characterization, treatment pathways, and patient related outcomes of Fragile X Syndrome
5
Health Supervision for Children With Fragile X Syndrome
15
Genomic studies in fragile X premutation carriers
8
Fragile X and company: Finding the right diagnosis
11
Testicular Torsion in an Adolescent With Fragile X Syndrome
5
Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI)
12
Proposed Mechanism of Inheritance and Expression of the Human Fragile-X Syndrome of Mental Retardation
13
Newborn, Carrier, and Early Childhood Screening Recommendations for Fragile X
12
Fragile X targeted pharmacotherapy: lessons learned and future directions
14
Advances in the Treatment of Fragile X Syndrome
15
Targeted treatments for fragile X syndrome
18
Modulation of the GABAergic pathway for the treatment of fragile X syndrome
11
Vocabulary comprehension in adults with fragile X syndrome (FXS)
9
Epigenetic mechanism of FMR1 inactivation in Fragile X syndrome
9
Fragile X mental retardation protein and synaptic plasticity
11
Health Supervision for Children With Fragile X Syndrome
6
FMRpolyG-positive inclusions in CNS and non-CNS organs of a fragile X premutation carrier with fragile X-associated tremor/ataxia syndrome
5
Conducting Research With an Adolescent Diagnosed With Fragile X Syndrome
22
X-inactivation in the clinical phenotype of fragile X premutation carrier sisters
7